Eli Lilly's drug tirzepatide significantly reduced the severity of obstructive sleep apnea (OSA) in obese adults, according to results from two phase 3 clinical trials. @EliLillyandCo #EliLilly #sleepapnea #pharmamanufacturing #pharmanews pharmamanufacturing.com/development/cl…
0
0
0
79
0
Download Image